Saturday, January 17, 2026 4:10:36 PM
The below confirmatory on LSE was expressed in 2015 by BASIN St BLUES (a London ForExchTrader) & switched his handle to SINGLE STOCK a few years ago
PGSD’s
BASIC ISSUE
OK95 was issued to NWBO in 2018
Even with MANNA from Hua Wei Sawston Sales/ leaseback nixed LSE
PRE Flaskwerks & non finished PH3 DC VAX L
NOW: How much longer administrative process for MHRA & NICE
Triggering Unveiling her hand & $ deals
PIVOTAL Question:
When will Cash strapped & debt laden reverse
To even begin to meet Jan 2026 LSE AIM listing requirements
ESPECIALLY requirement of having 12 mos of working capital for consideration
Bottomline
READ today’s posted 13 screenshots
Anything else I treat as PURE NONSENSE & Pie in the Sky
Too many Olympian high hurdles to flawlessly execute awaits
DIFFERENT STROKES for DIFFERENT FOLKS
PGSD’s
It is a sad (but true) reality that the stock market manipulation (and apparent complicit allowance by US Gov and Regulators) that you see on US stock markets is better regulated in the UK.
BASIC ISSUE
OK95 was issued to NWBO in 2018
Even with MANNA from Hua Wei Sawston Sales/ leaseback nixed LSE
PRE Flaskwerks & non finished PH3 DC VAX L
NOW: How much longer administrative process for MHRA & NICE
Triggering Unveiling her hand & $ deals
PIVOTAL Question:
When will Cash strapped & debt laden reverse
To even begin to meet Jan 2026 LSE AIM listing requirements
ESPECIALLY requirement of having 12 mos of working capital for consideration
Bottomline
READ today’s posted 13 screenshots
Anything else I treat as PURE NONSENSE & Pie in the Sky
Too many Olympian high hurdles to flawlessly execute awaits
DIFFERENT STROKES for DIFFERENT FOLKS
Recent NWBO News
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • InvestorsHub NewsWire • 05/11/2026 01:00:00 PM
- CNS Drug Delivery Breakthroughs Unlock Significant Biotech Market Opportunities • GlobeNewswire Inc. • 05/11/2026 12:30:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:38:00 PM
- Northwest Biotherapeutics Appoints Dr. Annalisa Jenkins As Strategic Adviser To Advance Dendritic Cell Cancer Vaccine Platform • PR Newswire (US) • 04/30/2026 04:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Northwest Biotherapeutics Announces Establishment Of the Company's Own Dedicated Leukapheresis Clinic • PR Newswire (US) • 04/21/2026 01:30:00 PM
- Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 04/21/2026 04:15:08 AM
- Form POS AM - Post-Effective amendments for registration statement • Edgar (US Regulatory) • 04/16/2026 09:25:30 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 04/07/2026 04:30:50 PM
- Form NT 10-K - Notification of inability to timely file Form 10-K 405, 10-K, 10-KSB 405, 10-KSB, 10-KT, or 10-KT405 • Edgar (US Regulatory) • 03/31/2026 09:04:37 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/15/2026 10:06:20 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/02/2026 10:14:59 PM
- Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 11/28/2025 09:43:27 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 11/25/2025 10:23:07 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/20/2025 09:26:03 PM
- Form PRE 14A - Other preliminary proxy statements • Edgar (US Regulatory) • 11/19/2025 09:15:48 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2025 09:44:21 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/31/2025 04:29:10 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2025 08:40:05 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/24/2025 04:28:38 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/14/2025 06:22:26 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 08/14/2025 09:00:38 PM
- Form 424B5 - Prospectus [Rule 424(b)(5)] • Edgar (US Regulatory) • 07/01/2025 09:04:38 PM
